Clinical Trial Update: Raltegravir and Atazanavir Dosing Strategy Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a dosing strategy for raltegravir with atazanavir in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• REYATAZ (atazanavir)

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infection | Phase 3 | Status: COMPLETED